Advisory Services Network LLC Buys 4,685 Shares of Stryker Corporation $SYK

Advisory Services Network LLC increased its stake in shares of Stryker Corporation (NYSE:SYK) by 23.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,621 shares of the medical technology company’s stock after acquiring an additional 4,685 shares during the quarter. Advisory Services Network LLC’s holdings in Stryker were worth $9,669,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Mid American Wealth Advisory Group Inc. purchased a new position in shares of Stryker during the second quarter valued at approximately $26,000. Elevation Point Wealth Partners LLC purchased a new stake in Stryker in the second quarter worth about $28,000. Sachetta LLC boosted its position in Stryker by 58.7% during the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock valued at $29,000 after acquiring an additional 27 shares in the last quarter. Kilter Group LLC bought a new stake in Stryker during the 2nd quarter valued at approximately $29,000. Finally, Howard Hughes Medical Institute purchased a new stake in Stryker in the second quarter worth $29,000. 77.09% of the stock is currently owned by institutional investors.

Insider Activity at Stryker

In related news, CAO William E. Berry, Jr. sold 1,953 shares of the stock in a transaction dated Friday, November 14th. The stock was sold at an average price of $365.49, for a total transaction of $713,801.97. Following the completion of the sale, the chief accounting officer owned 2,833 shares in the company, valued at approximately $1,035,433.17. This trade represents a 40.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Ronda E. Stryker sold 276,173 shares of the company’s stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $353.28, for a total transaction of $97,566,397.44. Following the transaction, the director owned 2,702,108 shares of the company’s stock, valued at approximately $954,600,714.24. This represents a 9.27% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 522,118 shares of company stock worth $185,381,932. 5.20% of the stock is owned by corporate insiders.

Stryker Price Performance

Shares of NYSE:SYK opened at $353.99 on Monday. The company has a quick ratio of 1.13, a current ratio of 1.85 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $135.37 billion, a PE ratio of 46.52, a price-to-earnings-growth ratio of 2.51 and a beta of 0.89. The firm’s 50 day moving average price is $366.81 and its 200-day moving average price is $378.45. Stryker Corporation has a twelve month low of $329.16 and a twelve month high of $406.19.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, October 30th. The medical technology company reported $3.19 earnings per share for the quarter, topping the consensus estimate of $3.13 by $0.06. The business had revenue of $6.06 billion for the quarter, compared to analysts’ expectations of $6.04 billion. Stryker had a net margin of 12.07% and a return on equity of 24.07%. The company’s revenue was up 10.2% compared to the same quarter last year. During the same quarter last year, the company posted $2.87 EPS. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. Equities research analysts expect that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be given a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Wednesday, December 31st. This is a positive change from Stryker’s previous quarterly dividend of $0.84. Stryker’s payout ratio is 44.15%.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Evercore ISI reduced their target price on shares of Stryker from $410.00 to $405.00 and set an “outperform” rating on the stock in a research report on Friday, October 31st. BTIG Research reiterated a “buy” rating and set a $410.00 target price on shares of Stryker in a report on Friday, November 14th. Needham & Company LLC reaffirmed a “buy” rating and set a $448.00 price objective on shares of Stryker in a research report on Friday, November 14th. Weiss Ratings restated a “hold (c+)” rating on shares of Stryker in a report on Monday, December 8th. Finally, Truist Financial raised their price objective on shares of Stryker from $392.00 to $400.00 and gave the company a “hold” rating in a research note on Friday, November 14th. Twelve analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $431.83.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.